Pfizer Inc
Change company Symbol lookup
Select an option...
PFE Pfizer Inc
EQ Equillium Inc
TSLA Tesla Inc
OPK OPKO Health Inc
PNW Pinnacle West Capital Corp
ROLL RBC Bearings Inc
GLAD Gladstone Capital Corp
PAC Grupo Aeroportuario del Pacifico SAB de CV
HQDA HQDA Elderly Life Network Corp
MDT Medtronic PLC
Go

Health Care : Pharmaceuticals | Large Cap Value
Company profile

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.

Closing Price
$35.48
Day's Change
0.20 (0.57%)
Bid
--
Ask
--
B/A Size
--
Day's High
35.54
Day's Low
34.84
Volume
(Below Average)
Volume:
24,334,779

10-day average volume:
27,917,947
24,334,779

Display:

Providers:

UpdateCancel
6 providers
Yesterday's News, October 30, 2020
Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and Upjohn

Mylan N.V. (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) today announced that the U.S. Federal Trade Commission (the "FTC") accepted a proposed consent order, which concludes the FTC's review of the proposed combination of Mylan and Pfizer's Upjohn...(PR Newswire)

Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and Upjohn

Mylan N.V. (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) today announced that the U.S. Federal Trade Commission (the "FTC") accepted a proposed consent order, which concludes the FTC's review of the proposed combination of Mylan and Pfizer's Upjohn...(BusinessWire)

Dr. Ellen R. Strahlman Elected to Altria's Board of Directors

Altria Group, Inc. (Altria) (NYSE:MO) announces that Dr. Ellen R. Strahlman will join its Board of Directors on November 2, 2020. Dr. Strahlman served as Executive Vice President, Research & Development and Chief Medical Officer of Becton...(BusinessWire)

October 27, 2020
Thinking about trading options or stock in AT&T, Pfizer, Royal Caribbean Cruises, American Airlines, or Qualcomm?

InvestorsObserver issues critical PriceWatch Alerts for T, PFE, RCL, AAL, and QCOM. https://mma.prnewswire.com/media/1086590/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)

Why Gastrointestinal (GI) Cancer Drugs Are Expected to See Significant Growth Over Next Few Years

Every year, the number of cancer-related deaths caused due to gastric cancer has been reaching to more than 800,000, as per the records of the World Health Organization. In the recent past, the number of people diagnosed with gastric cancer was...(PR Newswire)

FDA Grants Priority Review and EMA Accepts Regulatory Submission for Pfizer's Abrocitinib, an Oral Once-Daily JAK1 Inhibitor, for Patients 12 and Up with Moderate to Severe Atopic Dermatitis

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) accepted for filing and granted Priority Review designation to the company's New Drug Application (NDA) for abrocitinib (100mg and 200mg), an investigational...(BusinessWire)

PFIZER REPORTS THIRD-QUARTER 2020 RESULTS

Pfizer Inc. (NYSE: PFE) reported financial results for third-quarter 2020 and updated and tightened certain components of Total Company(3) 2020 financial guidance, which continues to reflect actual and anticipated business impacts from the novel...(BusinessWire)

October 23, 2020
Thinking about buying stock in Pfizer, Delta Air Lines, Norwegian Cruise Line, CTI BioPharma, or Honeywell?

InvestorsObserver issues critical PriceWatch Alerts for PFE, DAL, NCLH, CTIC, and HON. https://mma.prnewswire.com/media/1086590/InvestorsObserver_Logo.jpg To see how InvestorsObserver's proprietary scoring system rates these stocks, view the...(PR Newswire)

Diagnostic Testing Capabilities Improve in the Face of Global Turmoil

While biotech companies work on vaccines and possible treatments and medical device companies focus on patient monitoring solutions, many others have been working on improving testing options. For example, numerous companies are now racing to...(PR Newswire)

October 21, 2020
Data From Pfizer's Adult and Pediatric Clinical Trial Programs for 20-Valent Pneumococcal Conjugate Vaccine Presented at IDWeek 2020

Pfizer Inc. (NYSE:PFE) today announced the full analysis from one of its Phase 3 studies (NCT03760146), which evaluated the safety and immunogenicity of its 20-valent pneumococcal conjugate vaccine (20vPnC) candidate in adults 18 years of age or...(BusinessWire)

Vaccines Market to Advance Impressively, Exhibit a CAGR of 10.7% and Reach USD 104.87 Billion by 2027

The global vaccines market size is expected to reach USD 104.87 billion by 2027, exhibiting a CAGR of 10.7% during the forecast period. The ongoing clinical trials for COVID-19 vaccine will have a tremendous impact on the global market. (Globe Newswire)

October 20, 2020
Thinking about trading options or stock in Pfizer, Exxon Mobil, Verizon, Intel Corp, or Roku?

InvestorsObserver issues critical PriceWatch Alerts for PFE, XOM, VZ, INTC, and ROKU. https://mma.prnewswire.com/media/1086590/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)

Psychedelics Could Become the Next Health and Wellness Trend

Research continues to mount on the health benefits of psychedelic drugs like psilocybin and loosening government restrictions are completely changing the way the world views psychedelics. What was once reserved for teenagers tripping out in their...(PR Newswire)

October 19, 2020
Should you invest in Nio Inc, Nikola Corp, Pfizer, Snap, or Flex?

InvestorsObserver issues critical PriceWatch Alerts for NIO, NKLA, PFE, SNAP, and FLEX. https://mma.prnewswire.com/media/1086590/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)

2nd Annual Gabelli Funds - Columbia Business School Healthcare Symposium (Virtual)

Join us as we discuss today's pressing healthcare issues. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201019005535/en/ CO-HOSTS: Click Here to Register (BusinessWire)

October 16, 2020
Should you invest in Pfizer, Autodesk, Caterpillar, Vipshop Holdings, or JinkoSolar?

InvestorsObserver issues critical PriceWatch Alerts for PFE, ADSK, CAT, VIPS, and JKS. https://mma.prnewswire.com/media/1086590/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)

October 14, 2020
Robust Research & Development Results In Faster Growth Of The Global Biologics Market

The biologics market is highly concentrated, with a small number of large players. The top ten competitors in the market made up 67.4% of the total market. Major players in the market include Pfizer Inc., F. Hoffmann-La Roche AG, AbbVie Inc., Merck...(Globe Newswire)

Report [2020-2026] Oncology Biosimilars Market Size, Share, Trends, Growth, Analysis, Competitive Landscape, Revenue, Forecast

The global Oncology Biosimilars Market is poised for rapid growth as patents of expensive biologic drugs are on the verge of expiration. Key insights in this regard have been shared by Fortune Business Insights in a report, titled "Oncology...(Globe Newswire)

October 11, 2020
CStone Announces Completion of $200 million Share Sale to Pfizer

CStone Pharmaceuticals ("CStone", HKEX: 2616) announced today the completion of the Share Subscription Agreement through which an affiliate of Pfizer Inc. ("Pfizer", NYSE: PFE) subscribed for newly issued CStone shares at approximately US$200...(PR Newswire)

October 09, 2020
PENELOPE-B Trial of IBRANCE(R) (palbociclib) in Early Breast Cancer Did Not Meet Primary Endpoint

The German Breast Group (GBG) and Pfizer Inc. (NYSE: PFE) today announced that the collaborative Phase 3 PENELOPE-B trial did not meet the primary endpoint of improved invasive disease-free survival (iDFS) in women with hormone receptor-positive...(BusinessWire)

Next >

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.